Sickle cell patients often face challenges when implementing their care plans. Columnist Mary Shaniqua describes what good ...
Invisible complications of sickle cell disease can result in a lack of understanding and proper care, says columnist.
Kanglin Biotechnology has raised $20 million in financing to advance the development of sickle cell gene therapy KL003.
Most sickle cell disease patients who received the gene-editing therapy Casgevy have been free from vaso-occlusive crises for ...
The majority of SCD patients given Lyfgenia in clinical trials remained free of vaso-occlusive events (VOEs) following ...
Sites in Los Angeles and near San Francisco California are enrolling people with severe SCD for a trial to test a gene ...
It’s almost winter again here in the U.K., and every year I’m shocked by the cold weather and its impact on my body. Winter has always been one of my greatest adversaries, and as the seasons shift, ...
I recently wrote about my disappointment regarding Pfizer’s decision to withdraw Oxbryta (voxelotor) from global markets as a treatment option for sickle cell disease. Therefore, it seems only fitting ...
The Clinton Health Access Initiative (CHAI) is leading a project that aims to expand access to diagnostic tests and treatments for sickle cell disease (SCD). The project is being funded by a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback